{"hands_on_practices": [{"introduction": "Cancer progression often involves the breakdown of critical safety mechanisms. This exercise provides a quantitative framework for understanding how the hallmark of 'evading growth suppressors' can arise from failures in multiple components of a regulatory network. By modeling the inactivation of the crucial $TP53$ tumor suppressor pathway as a probabilistic event, you will apply fundamental probability principles to calculate the overall vulnerability of the system, illustrating how independent failures can collectively contribute to a cancerous phenotype [@problem_id:4391982].", "problem": "Consider the hallmark of cancer known as evading growth suppressors, in which disruption of the Tumor Protein 53 (TP53) pathway is a common systems-level mechanism. Model pathway inactivation as the failure of at least one of two regulatory components: Tumor Protein 53 (TP53) function and Mouse Double Minute 2 Homolog (MDM2) regulation. Assume a tumor cell population in which, over a defined exposure window, TP53 failure occurs as a Bernoulli event with probability $p_1 = 0.3$, and MDM2 regulatory failure occurs independently as a Bernoulli event with probability $p_2 = 0.2$. Inactivation of the TP53 pathway is triggered if either TP53 fails or MDM2 regulation fails. Using only fundamental probability principles and the independence assumption, compute the probability that the TP53 pathway is inactivated. Express your final answer as a decimal number. No rounding is required, and no units are associated with the probability.", "solution": "The problem statement is subjected to validation before a solution is attempted.\n\n### Step 1: Extract Givens\n- **Context**: The hallmark of cancer known as \"evading growth suppressors\".\n- **System**: The Tumor Protein 53 (TP53) pathway.\n- **Inactivation Condition**: The pathway is inactivated if at least one of two components fails.\n- **Component 1**: Tumor Protein 53 (TP53) function.\n- **Event 1**: TP53 failure, modeled as a Bernoulli event.\n- **Probability of Event 1**: $p_1 = 0.3$.\n- **Component 2**: Mouse Double Minute 2 Homolog (MDM2) regulation.\n- **Event 2**: MDM2 regulatory failure, modeled as a Bernoulli event.\n- **Probability of Event 2**: $p_2 = 0.2$.\n- **Independence**: The two failure events are assumed to be independent.\n- **Objective**: Compute the probability that the TP53 pathway is inactivated.\n- **Constraints**: Use only fundamental probability principles and the independence assumption. The final answer must be a decimal number.\n\n### Step 2: Validate Using Extracted Givens\n1.  **Scientifically Grounded**: The problem is grounded in established concepts of systems oncology. The TP53 pathway, its role as a tumor suppressor, and its regulation by MDM2 are fundamental concepts in cancer biology. Modeling component failures as probabilistic events is a standard approach in systems-level analysis. The problem is a simplified but scientifically plausible representation of a biological process.\n2.  **Well-Posed**: The problem is well-posed. It provides all necessary information: the probabilities of two independent events and a clear logical condition (an \"OR\" condition) for the event of interest. This structure guarantees that a unique, stable, and meaningful solution exists.\n3.  **Objective**: The problem is stated in precise, objective language. Terms like \"Bernoulli event\" and \"independently\" have unambiguous mathematical definitions.\n\n### Step 3: Verdict and Action\nThe problem is deemed **valid** as it is scientifically grounded, well-posed, objective, and self-contained. A solution will be provided.\n\n### Solution Derivation\nThe problem requires the calculation of the probability of an event defined by the union of two independent sub-events. Let us formalize the events based on the provided information.\n\nLet $A$ be the event that TP53 function fails. The probability of this event is given as $P(A) = p_1 = 0.3$.\nLet $B$ be the event that MDM2 regulation fails. The probability of this event is given as $P(B) = p_2 = 0.2$.\n\nThe problem states that the TP53 pathway is inactivated if \"either TP53 fails or MDM2 regulation fails.\" This corresponds to the logical OR operation, which in probability theory is the union of events $A$ and $B$, denoted as $A \\cup B$. We are asked to compute $P(A \\cup B)$.\n\nAccording to the principle of inclusion-exclusion for two events, the probability of their union is given by:\n$$P(A \\cup B) = P(A) + P(B) - P(A \\cap B)$$\nwhere $P(A \\cap B)$ is the probability that both events $A$ and $B$ occur (their intersection).\n\nThe problem explicitly states that the two events, TP53 failure and MDM2 failure, are independent. By the definition of independent events, the probability of their intersection is the product of their individual probabilities:\n$$P(A \\cap B) = P(A) \\times P(B)$$\n\nSubstituting the given probabilities:\n$$P(A \\cap B) = p_1 \\times p_2 = 0.3 \\times 0.2 = 0.06$$\n\nNow, we can substitute this result back into the inclusion-exclusion formula:\n$$P(A \\cup B) = P(A) + P(B) - P(A \\cap B) = 0.3 + 0.2 - 0.06$$\n$$P(A \\cup B) = 0.5 - 0.06 = 0.44$$\n\nAlternatively, one can solve this problem by considering the complement event. The complement of the pathway being inactivated is that the pathway remains functional. This occurs only if *both* TP53 function is intact *and* MDM2 regulation is intact.\n\nLet $A^c$ be the complement of event $A$, representing that TP53 function is intact. The probability is:\n$$P(A^c) = 1 - P(A) = 1 - 0.3 = 0.7$$\nLet $B^c$ be the complement of event $B$, representing that MDM2 regulation is intact. The probability is:\n$$P(B^c) = 1 - P(B) = 1 - 0.2 = 0.8$$\n\nThe event that the pathway remains functional is the intersection of these two complement events, $A^c \\cap B^c$. Since events $A$ and $B$ are independent, their complements $A^c$ and $B^c$ are also independent. Therefore, the probability that the pathway is functional is:\n$$P(A^c \\cap B^c) = P(A^c) \\times P(B^c) = 0.7 \\times 0.8 = 0.56$$\n\nThe probability of the pathway being inactivated, $P(A \\cup B)$, is the complement of the pathway remaining functional. According to De Morgan's laws, $(A \\cup B)^c = A^c \\cap B^c$. Thus:\n$$P(A \\cup B) = 1 - P((A \\cup B)^c) = 1 - P(A^c \\cap B^c)$$\n$$P(A \\cup B) = 1 - 0.56 = 0.44$$\n\nBoth methods yield the same result, confirming the correctness of the calculation. The probability that the TP53 pathway is inactivated is $0.44$.", "answer": "$$\\boxed{0.44}$$", "id": "4391982"}, {"introduction": "The net growth of a tumor is a dynamic balance between cell proliferation and cell death, reflecting the interplay between the hallmarks of 'sustaining proliferative signaling' and 'resisting cell death'. This practice introduces a simple but powerful ordinary differential equation (ODE) to model this balance and explore its long-term consequences. By performing an equilibrium analysis, you will derive the critical condition required for a tumor to establish a persistent population and quantify how apoptosis impacts the final tumor size [@problem_id:4392029].", "problem": "A tumor cell population within a confined microenvironment is modeled by density-dependent proliferation with an explicit per-capita apoptosis term, reflecting the balance between the hallmarks of sustaining proliferative signaling and resisting cell death. Let $N(t)$ denote the tumor cell number at time $t$. Consider the ordinary differential equation (ODE)\n$$\n\\frac{dN}{dt} \\;=\\; r\\,N\\left(1-\\frac{N}{K}\\right) \\;-\\; k_a\\,N \\;=\\; \\bigg[r\\left(1-\\frac{N}{K}\\right) - k_a\\bigg]\\,N,\n$$\nwhere $r$ is the baseline per-capita proliferation rate in the absence of density limitation, $K$ is the carrying capacity imposed by resource limitations, and $k_a$ is the per-capita apoptosis rate.\n\nStarting only from the definitions of equilibrium (i.e., $\\frac{dN}{dt}=0$) and the given ODE, derive the nonzero equilibrium $N^{\\ast}$ as a function of $r$, $K$, and $k_a$, and interpret its feasibility condition in terms of the competition between proliferation and apoptosis. Then, with $r=0.5$ day$^{-1}$, $K=10^{9}$ cells, and $k_a=0.1$ day$^{-1}$, compute the dimensionless ratio\n$$\nR \\;=\\; \\frac{N^{\\ast}(k_a=0.1\\ \\text{day}^{-1})}{N^{\\ast}(k_a=0)},\n$$\nwhich quantifies the equilibrium tumor burden under apoptosis relative to the hypothetical case of complete evasion of apoptosis (i.e., $k_a=0$). Report the final value of $R$ as a decimal rounded to three significant figures.", "solution": "The problem statement is scientifically grounded, well-posed, and contains all necessary definitions and data for a unique solution. The model presented is a standard extension of the logistic growth equation, commonly used in mathematical biology to describe population dynamics with a constant per-capita death rate. Therefore, the problem is deemed valid and a solution will be furnished.\n\nThe dynamics of the tumor cell population are described by the ordinary differential equation (ODE):\n$$\n\\frac{dN}{dt} \\;=\\; \\bigg[r\\left(1-\\frac{N}{K}\\right) - k_a\\bigg]\\,N\n$$\nEquilibrium points, which we denote as $N^{\\ast}$, are the values of $N$ for which the population size does not change over time. This corresponds to the condition $\\frac{dN}{dt} = 0$. Applying this condition to the given ODE yields:\n$$\n\\bigg[r\\left(1-\\frac{N^{\\ast}}{K}\\right) - k_a\\bigg]\\,N^{\\ast} = 0\n$$\nThis equation has two solutions for $N^{\\ast}$. The first is the trivial equilibrium, $N^{\\ast}_1 = 0$, which represents the complete absence or extinction of the tumor cell population.\n\nThe nonzero equilibrium, which is the focus of the problem, is found by setting the term in the square brackets to zero, assuming $N^{\\ast} \\neq 0$:\n$$\nr\\left(1-\\frac{N^{\\ast}}{K}\\right) - k_a = 0\n$$\nWe now solve this equation for $N^{\\ast}$ to express it as a function of the parameters $r$, $K$, and $k_a$.\n$$\nr - \\frac{r N^{\\ast}}{K} - k_a = 0\n$$\nRearranging the terms to isolate the term containing $N^{\\ast}$:\n$$\nr - k_a = \\frac{r N^{\\ast}}{K}\n$$\nMultiplying both sides by $\\frac{K}{r}$ gives the expression for the nonzero equilibrium:\n$$\nN^{\\ast} = \\frac{K}{r}(r - k_a)\n$$\nThis can be written in a more illustrative form by distributing the factor $\\frac{K}{r}$:\n$$\nN^{\\ast} = K\\left(1 - \\frac{k_a}{r}\\right)\n$$\nThe feasibility condition for this nonzero equilibrium is that it must be a physically meaningful quantity, i.e., a positive population size ($N^{\\ast} > 0$). Since the carrying capacity $K$ is inherently positive ($K>0$), the feasibility condition reduces to:\n$$\n1 - \\frac{k_a}{r} > 0\n$$\nThis inequality simplifies to $1 > \\frac{k_a}{r}$, or $r > k_a$. The biological interpretation is clear: for a viable tumor population to be sustained at a nonzero level, the baseline per-capita proliferation rate ($r$) must be greater than the per-capita apoptosis rate ($k_a$). If $k_a \\geq r$, the rate of cell death matches or exceeds the maximum possible rate of proliferation, leading to the collapse of the population to the trivial equilibrium, $N^{\\ast}=0$.\n\nThe problem asks for the computation of the dimensionless ratio $R$:\n$$\nR \\;=\\; \\frac{N^{\\ast}(k_a=0.1\\ \\text{day}^{-1})}{N^{\\ast}(k_a=0)}\n$$\nFirst, we determine the denominator, $N^{\\ast}(k_a=0)$, which represents the equilibrium population in a hypothetical scenario with no apoptosis. Substituting $k_a=0$ into the expression for $N^{\\ast}$:\n$$\nN^{\\ast}(k_a=0) = K\\left(1 - \\frac{0}{r}\\right) = K(1) = K\n$$\nAs expected, in the absence of the apoptosis term, the equilibrium is simply the carrying capacity $K$ from the standard logistic model.\n\nNow, we can write the ratio $R$ using the general expression for $N^{\\ast}$:\n$$\nR = \\frac{K\\left(1 - \\frac{k_a}{r}\\right)}{K} = 1 - \\frac{k_a}{r}\n$$\nWe are given the parameter values $r=0.5$ day$^{-1}$ and $k_a=0.1$ day$^{-1}$. Substituting these values into the expression for $R$:\n$$\nR = 1 - \\frac{0.1 \\text{ day}^{-1}}{0.5 \\text{ day}^{-1}} = 1 - \\frac{1}{5} = 1 - 0.2 = 0.8\n$$\nThe problem requires the answer to be a decimal rounded to three significant figures. Therefore, we express the result as $0.800$.", "answer": "$$\\boxed{0.800}$$", "id": "4392029"}, {"introduction": "A fundamental hallmark of cancer is the reprogramming of cellular metabolism to fuel growth and proliferation, often driven by oncogenic signaling pathways. This practice delves into the mechanics of this process by building a quantitative model of glucose uptake and phosphorylation, the initial steps of glycolysis. You will use established kinetic principles, such as Michaelis-Menten equations, to analyze how signaling through the PI3K/AKT pathway can alter metabolic flux, providing a concrete example of systems-level control over cellular energetics [@problem_id:4392042].", "problem": "A proliferating cancer cell reprograms glucose uptake and phosphorylation through Phosphoinositide 3-kinase (PI3K) and AKT serine/threonine kinase (AKT) signaling, altering the glucose transporter (GLUT) capacity and hexokinase (HK) activity. Consider a single-compartment toy glycolysis initiation module with constant extracellular glucose concentration $G_{e}$ and cytosolic free glucose concentration $G(t)$.\n\nUse the following physically motivated and widely used kinetic forms as the foundational starting point:\n- Carrier-mediated facilitated diffusion of glucose across the membrane by a symmetric rapid-equilibrium transporter: the net transport flux is\n$$\nJ_{T}(G) \\;=\\; V_{T}\\,\\frac{G_{e}-G}{K_{T}+G_{e}+G},\n$$\nwith $V_{T}$ the maximal transport capacity and $K_{T}$ an apparent affinity constant.\n- Hexokinase phosphorylation of cytosolic glucose follows Michaelisâ€“Menten kinetics:\n$$\nJ_{H}(G) \\;=\\; V_{H}\\,\\frac{G}{K_{H}+G},\n$$\nwith $V_{H}$ the maximal velocity and $K_{H}$ the Michaelis constant.\n\nAssume mass balance for cytosolic glucose,\n$$\n\\frac{dG}{dt} \\;=\\; J_{T}(G) \\;-\\; J_{H}(G),\n$$\nand a quasi-steady-state $dG/dt=0$ in which downstream metabolism of glucose-6-phosphate is not rate-limiting.\n\n1) Starting from these definitions and mass balance, derive an explicit algebraic equation for the steady-state $G^{\\ast}$ and show that it reduces to a quadratic in $G^{\\ast}$. Write the coefficients in terms of $V_{T}$, $V_{H}$, $K_{T}$, $K_{H}$, and $G_{e}$.\n\n2) The net steady-state glycolytic entry flux is $J^{\\ast} = J_{H}(G^{\\ast}) = J_{T}(G^{\\ast})$. Using the quadratic from part (1), compute $J^{\\ast}$ for the baseline parameter set\n$$\nG_{e}=2.0 \\text{ mM},\\quad V_{T}=4.0 \\text{ mM}\\,\\text{min}^{-1},\\quad K_{T}=5.0 \\text{ mM},\\quad V_{H}=3.0 \\text{ mM}\\,\\text{min}^{-1},\\quad K_{H}=0.050 \\text{ mM}.\n$$\n\n3) Model PI3K/AKT activation as simultaneous multiplicative increases in transporter capacity and hexokinase activity:\n$$\nV_{T}\\to a_{T}V_{T},\\qquad V_{H}\\to a_{H}V_{H},\n$$\nwith $a_{T}=2.0$ and $a_{H}=1.5$; all other parameters remain unchanged. Recompute the steady-state flux $J^{\\ast}_{\\mathrm{AKT}}$ under activation.\n\nReport the fold-change in net glycolytic entry flux,\n$$\nF \\;=\\; \\frac{J^{\\ast}_{\\mathrm{AKT}}}{J^{\\ast}_{\\mathrm{baseline}}},\n$$\nas the final answer. Express $F$ as a decimal rounded to four significant figures. No units are required for $F$; if you compute intermediate fluxes, express them in $\\text{mM}\\,\\text{min}^{-1}$.", "solution": "The problem is valid as it is scientifically grounded in biochemical kinetics, mathematically well-posed, and all necessary information is provided.\n\n**1) Derivation of the quadratic equation for steady-state glucose concentration $G^{\\ast}$**\nThe dynamics of the cytosolic glucose concentration $G(t)$ are given by the mass balance equation:\n$$\n\\frac{dG}{dt} = J_{T}(G) - J_{H}(G)\n$$\nAt a quasi-steady-state, the concentration does not change over time, so $\\frac{dG}{dt} = 0$. This implies that the influx of glucose equals its consumption rate, $J_{T}(G^{\\ast}) = J_{H}(G^{\\ast})$, where $G^{\\ast}$ is the steady-state concentration.\nSubstituting the given kinetic forms:\n$$\nV_{T}\\,\\frac{G_{e}-G^{\\ast}}{K_{T}+G_{e}+G^{\\ast}} = V_{H}\\,\\frac{G^{\\ast}}{K_{H}+G^{\\ast}}\n$$\nTo obtain an algebraic equation for $G^{\\ast}$, we cross-multiply:\n$$\nV_{T}(G_{e}-G^{\\ast})(K_{H}+G^{\\ast}) = V_{H}G^{\\ast}(K_{T}+G_{e}+G^{\\ast})\n$$\nWe expand both sides of the equation.\nLeft side:\n$$\nV_{T}(G_{e}K_{H} + G_{e}G^{\\ast} - G^{\\ast}K_{H} - (G^{\\ast})^2) = V_{T}G_{e}K_{H} + (V_{T}G_{e} - V_{T}K_{H})G^{\\ast} - V_{T}(G^{\\ast})^2\n$$\nRight side:\n$$\nV_{H}(G^{\\ast}K_{T} + G^{\\ast}G_{e} + (G^{\\ast})^2) = (V_{H}K_{T} + V_{H}G_{e})G^{\\ast} + V_{H}(G^{\\ast})^2\n$$\nEquating the expanded expressions and collecting terms by powers of $G^{\\ast}$:\n$$\nV_{T}G_{e}K_{H} + (V_{T}G_{e} - V_{T}K_{H})G^{\\ast} - V_{T}(G^{\\ast})^2 = (V_{H}K_{T} + V_{H}G_{e})G^{\\ast} + V_{H}(G^{\\ast})^2\n$$\nRearranging into the standard quadratic form $A(G^{\\ast})^2 + B G^{\\ast} + C = 0$:\n$$\n(V_{T}+V_{H})(G^{\\ast})^2 + (V_{H}K_{T} + V_{H}G_{e} - V_{T}G_{e} + V_{T}K_{H})G^{\\ast} - V_{T}G_{e}K_{H} = 0\n$$\nThe coefficients of the quadratic equation are:\n$$\nA = V_{T} + V_{H}\n$$\n$$\nB = V_{H}(K_{T} + G_{e}) + V_{T}(K_{H} - G_{e})\n$$\n$$\nC = -V_{T}G_{e}K_{H}\n$$\n\n**2) Calculation of the baseline steady-state flux $J^{\\ast}$**\nWe are given the baseline parameter set:\n$G_{e}=2.0 \\text{ mM}$, $V_{T}=4.0 \\text{ mM}\\,\\text{min}^{-1}$, $K_{T}=5.0 \\text{ mM}$, $V_{H}=3.0 \\text{ mM}\\,\\text{min}^{-1}$, $K_{H}=0.050 \\text{ mM}$.\n\nFirst, we compute the coefficients $A$, $B$, and $C$:\n$$\nA = 4.0 + 3.0 = 7.0\n$$\n$$\nB = 3.0(5.0 + 2.0) + 4.0(0.050 - 2.0) = 3.0(7.0) + 4.0(-1.95) = 21.0 - 7.8 = 13.2\n$$\n$$\nC = -4.0 \\times 2.0 \\times 0.050 = -0.40\n$$\nThe quadratic equation for the baseline steady-state glucose concentration $G^{\\ast}_{\\mathrm{baseline}}$ is:\n$$\n7.0(G^{\\ast}_{\\mathrm{baseline}})^2 + 13.2G^{\\ast}_{\\mathrm{baseline}} - 0.40 = 0\n$$\nWe solve for $G^{\\ast}_{\\mathrm{baseline}}$ using the quadratic formula, $G^{\\ast} = \\frac{-B \\pm \\sqrt{B^2 - 4AC}}{2A}$. Since concentration must be a non-negative quantity, we take the positive root.\n$$\nG^{\\ast}_{\\mathrm{baseline}} = \\frac{-13.2 + \\sqrt{(13.2)^2 - 4(7.0)(-0.40)}}{2(7.0)} = \\frac{-13.2 + \\sqrt{174.24 + 11.2}}{14} = \\frac{-13.2 + \\sqrt{185.44}}{14}\n$$\n$$\nG^{\\ast}_{\\mathrm{baseline}} \\approx \\frac{-13.2 + 13.6176}{14} \\approx 0.02983 \\text{ mM}\n$$\nThe steady-state glycolytic entry flux is $J^{\\ast} = J_{H}(G^{\\ast})$. Using the baseline parameters:\n$$\nJ^{\\ast}_{\\mathrm{baseline}} = V_{H}\\frac{G^{\\ast}_{\\mathrm{baseline}}}{K_{H}+G^{\\ast}_{\\mathrm{baseline}}} = 3.0 \\times \\frac{0.029831}{0.050 + 0.029831} \\approx 3.0 \\times \\frac{0.029831}{0.079831} \\approx 1.12102 \\text{ mM}\\,\\text{min}^{-1}\n$$\n\n**3) Recomputation of the steady-state flux under PI3K/AKT activation**\nPI3K/AKT activation is modeled by $V_{T} \\to a_{T}V_{T}$ and $V_{H} \\to a_{H}V_{H}$, with $a_{T}=2.0$ and $a_{H}=1.5$.\nThe new parameters, denoted with a prime, are:\n$$\nV'_{T} = 2.0 \\times 4.0 = 8.0 \\text{ mM}\\,\\text{min}^{-1}\n$$\n$$\nV'_{H} = 1.5 \\times 3.0 = 4.5 \\text{ mM}\\,\\text{min}^{-1}\n$$\nAll other parameters ($G_{e}$, $K_{T}$, $K_{H}$) remain unchanged. We recompute the quadratic coefficients $A'$, $B'$, $C'$:\n$$\nA' = V'_{T} + V'_{H} = 8.0 + 4.5 = 12.5\n$$\n$$\nB' = V'_{H}(K_{T} + G_{e}) + V'_{T}(K_{H} - G_{e}) = 4.5(5.0 + 2.0) + 8.0(0.050 - 2.0) = 4.5(7.0) + 8.0(-1.95) = 31.5 - 15.6 = 15.9\n$$\n$$\nC' = -V'_{T}G_{e}K_{H} = -8.0 \\times 2.0 \\times 0.050 = -0.80\n$$\nThe new quadratic equation for $G^{\\ast}_{\\mathrm{AKT}}$ is:\n$$\n12.5(G^{\\ast}_{\\mathrm{AKT}})^2 + 15.9G^{\\ast}_{\\mathrm{AKT}} - 0.80 = 0\n$$\nSolving for the positive root of $G^{\\ast}_{\\mathrm{AKT}}$:\n$$\nG^{\\ast}_{\\mathrm{AKT}} = \\frac{-15.9 + \\sqrt{(15.9)^2 - 4(12.5)(-0.80)}}{2(12.5)} = \\frac{-15.9 + \\sqrt{252.81 + 40}}{25} = \\frac{-15.9 + \\sqrt{292.81}}{25}\n$$\n$$\nG^{\\ast}_{\\mathrm{AKT}} \\approx \\frac{-15.9 + 17.1117}{25} \\approx 0.048468 \\text{ mM}\n$$\nThe new steady-state flux $J^{\\ast}_{\\mathrm{AKT}}$ is calculated using the updated parameters:\n$$\nJ^{\\ast}_{\\mathrm{AKT}} = V'_{H}\\frac{G^{\\ast}_{\\mathrm{AKT}}}{K_{H}+G^{\\ast}_{\\mathrm{AKT}}} = 4.5 \\times \\frac{0.048468}{0.050 + 0.048468} \\approx 4.5 \\times \\frac{0.048468}{0.098468} \\approx 2.21497 \\text{ mM}\\,\\text{min}^{-1}\n$$\n\n**Final Calculation: Fold-Change in Flux**\nThe fold-change $F$ is the ratio of the activated flux to the baseline flux:\n$$\nF = \\frac{J^{\\ast}_{\\mathrm{AKT}}}{J^{\\ast}_{\\mathrm{baseline}}}\n$$\nUsing the computed flux values:\n$$\nF = \\frac{2.21497}{1.12102} \\approx 1.97585\n$$\nRounding to four significant figures, the fold-change is $1.976$.", "answer": "$$\\boxed{1.976}$$", "id": "4392042"}]}